Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Merck manufactures Ivermectin which is highly effective against COVID-19
Why are they trying to market a new pill that is half as effective for 40x greater price?
Here is some data on Merck's Ivermectin used against COVID-19:
MRK isn't reacting well to news about its new $700 treatment compared to its other product, Ivermectin which costs $10-$20 per treatment.
Loving these prices, looking forward to 100.00 break ahead IMO
$MRK
WHAT KIND OF CON ARTISTS RUN THIS COMPANY?
$700 PER TREATMENT? ARE THEY SERIOUS????
IVERMECTIN $10-$20 IN COMPARISON.....
AND CONSIDERING MERCK'S NEW PILL IS HALF AS EFFECTIVE THAT ACTUAL COMPARISON IS $10-$20 VS $1,400
MERCK SHOULD BE CHARGED FOR FRAUD!!!!!!!
RIPPING OFF SICK PEOPLE IS DESPICABLE!!!!!!!!!
Molnupiravir’s mechanism of action makes it a scary drug:
https://www.barrons.com/articles/merck-covid-pill-risks-51633398722
https://academic.oup.com/jid/article/224/3/415/6272009
Anyone who's afraid of taking a COVID-19 vaccine would have to be nuts to get treated with molnupiravir. (Disclosure: I'm long ENTA.)
agree, rynlrt -- the news flow for MRK has been overwhelmingly positive.
Allowed me to buy some cheap calls at least. I'd expect a jump through this week and next
neither was i, especially with markets up, as they were. but there's usually a bullish explanation for these pullbacks. i'm sure plenty of whales/institutions want a piece of MRK before significant news hits.
Definitely wasn't expecting it to fall today. Then again it's bloody Tuesday
i'm buying $90 11/5 calls at .42 right now, bidding more lower. let's drop this MRK.
MRK is closing deals to sell their pills yet we are down. Doesnt make sense
$MRK Merck anti-viral Covid drug is an 'important advance,' says Dr. Fauci
CNBC
$Mrk SVB Leerink On Merck Price Target Raise: Firm Highlights Molnupiravir In Treating Covid-19 Patients With Symptoms <5 Days & At Least One Risk Factor For Severe Diseases; Notes 1.7M Supply Commitment To U.S. & Guided Manufacturing Capacity of 10M
$MRK U.S. COVID-19 pushed death toll above 700,000
$MRK high estimate of 107.00
$MRK ++> up but Makers of vaccines and other coronavirus treatments dropped in Asia after Merck & Co. said its experimental pill cuts the risk of hospitalization and death from Covid-19 in half.
https://finance.yahoo.com/news/merck-covid-pill-progress-sparks-032137046.html
Magic the wonder-horse loves MRK !!
There are 2.5 BILLION share OS. Trading float is also 2.5 BILLION shares, according to MarketWatch.
FDA Approval will take months. Hope to have FDA's EUA later this month.
$300 price target on this once FDA approves, the US government is already buying ptosis. Approval will come any day now
OK got it, cept the vaccine people don't want the pill, of course, but whos dying and whos lyning, gotta get it straight
A great bet to beat COVID-19 Symptoms…. I’m all in!!!!! FDA decision any day
$MRK Merck & Co shares are trading higher after SVB Leerink maintained an Outperform rating on the stock and raised its price target from $101 to $104.
Now it's stalled, do they have the API ?, can they produce? can they make a billion pills , They need to make some deals, and fast, there are many idle pharma factories due to the pandemic, it takes a minimum 6 months to get the average facility back up and running after closer. Lets do this with Elite
Yep crude, the world needs this anti viral pill, lets hope it works and lets hope Merck uses Elite Pharma to help make the pills, they can do it.
Hey Budget! You have to brand a "MRK" symbol on your horse. ( lol, at lesst on your pic ).
Sometimes it’s just too easy !!
Even my horse will take pills…….lol.
(Hi Crude…….!!)
$$ MRK $$
MRK is and will be a 200 plus stock.
SVB Leerink analyst Daina Graybosch maintains Merck & Co (NYSE:MRK) with a Outperform and raises the price target from $101 to $104.
MRK
Exactly! > Waiting for EUA to go full throttle.
MRK could use some help, Elite's plant, just down the road from Merck, sits idle most of the time, they can pump out 700 million pills a year.
EUA may happen over the next six to eight weeks.
Merck pill is a therapeutic. Pfizer product is a vaccine.
The Japanese government is in talks to procure Merck & Co.'s potential Covid-19 drug as soon as the end of the year, Japanese business daily Nikkei reported Sunday without citing sources.
--If the drug is approved in the U.S. and an application is made in Japan, the country's health ministry would consider approving the drug through an expedited process, the Nikkei report said.
Full story: https://s.nikkei.com/3Bk4rfm (Japanese)
Write to Kosaku Narioka at kosaku.narioka@wsj.com
MRK
MRK has a complimentary market to Pfizer. anyone with a breakthrough COVID case can take the pill to reduce their odds of morbidity and mortality. same goes for anyone who didn't get vaxed.
Really great!
Been watching this. The Merck pill has promise but I don't think the FDA will approve it. Pfizer bought and paid for Fauci and the FDA. If this pill is approved, that would cost Pfizer billions. Hope I'm wrong, just my opinion.
"Game changer' — Cramer says Merck's new Covid pill could send stock even higher https://www.cnbc.com/2021/10/01/cramer-says-mercks-new-covid-pill-could-send-stock-even-higher.html?__source=iosappshare%7Ccom.apple.UIKit.activity.CopyToPasteboard
Best stock to run with the best med !!! Definitely well over @100 !!!!
$100+ coming $MRK
$MRK has $8.59 Billion in cash
Here comes the 90s. Fauci says FDA will review Merck’s new Covid treatment ‘as quickly as they possibly can’
PUBLISHED FRI, OCT 1 20215:33 PM EDTUPDATED 8 MIN AGO
Robert Towey
@ROBERTTOWEYCNBC
Dr. Anthony Fauci said Friday the FDA will review data on Merck and Ridgeback Biotherapeutics’ new Covid oral antiviral quickly in hopes of issuing an emergency use authorization.
The companies said their treatment, molnupiravir, reduced the risk of hospitalization or death for unvaccinated patients with mild or moderate Covid by about 50%.
In the phase three clinical trial, which had 775 participants who took either molnupiravir or a placebo, eight people who took the placebo died within 29 days. None of the participants who took molnupiravir died.
Followers
|
63
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
875
|
Created
|
07/04/06
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |